# Verdict: dicer1_syndrome.md (re-verification after R1 rework)

1. DOSE LEAK: none. Grepped for mg/mg-m2/AUC/q-schedule/day-N/cycle-N tokens — zero hits.
   Treatment language stays at modality level ("surgical resection," "systemic chemotherapy,"
   "radiotherapy") with no doses, AUC targets, or numbered schedules.

2. UNGROUNDED / MISLABELLED CLAIMS: none. The file names no specific drugs, trial names, or
   statistics anywhere, so no claim requires a grounding label. Re-grepped DeVita for the
   disease and its component tumors:
   - `dicer1` → exactly one hit in the whole corpus (line ~67933), an incidental
     somatic-mutation mention in a pulmonary-blastoma molecular-pathology list — no
     management content.
   - `pleuropulmonary` → exactly one hit (line 67647), a WHO-classification table-of-contents
     entry with no accompanying narrative section.
   This corroborates the opening note's claim that DeVita has no dedicated DICER1-syndrome
   section. No sentence in the body attributes anything to DeVita.

3. CITATION: `Sources: NCCN Guidelines. DICER1/PPB Registry international surveillance
   consensus (Schultz et al.).` — name only, no page numbers. DeVita is correctly no longer
   cited here (it was mis-cited in the prior draft; now removed per R1).

4. Fixes from the prior REVISE verdict, verified:
   - FLAG block (lines 3-8 of the old draft): gone. `grep FLAG` = no hits. Replaced with a
     single plain-worded attribution note (current lines 3-6), stated once, not alarm-styled.
   - The 15+ repeated "(general oncology standard, not from DeVita's section...)" inline
     parentheticals: all removed from the bullets; attribution is now out-of-band in the
     opening note only. `grep "general oncology standard"` = no hits in the body.
   - Sources footer DeVita mis-citation: removed; footer now cites only NCCN + Schultz et
     al. registry consensus, matching what the content actually is.
   - No em/en dashes: confirmed, zero hits.

VERDICT: CLEAN — ready for R1 re-review.
